Thomas Patrick Kelly
Chief Financial Officer
Common Shares
- Reported value
- $559.74K
- Reported price
- $37.316 / share
Xenon Pharmaceuticals Inc.
Last 30 daysInsiders bought $1.68M · 2 buyers, led by Ian Mortimer (CEO) with $1.12M. No qualifying insider sales.
Showing the first 6 of 41 trades on this page.
Chief Financial Officer
Common Shares
PRESIDENT & CEO
Common Shares
Director
Common Shares
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Common Shares
Chief Medical Officer
Common Shares
Director
Common Shares
Director
Common Shares
Director
Common Shares
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Common Shares
Director
Restricted Share Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Share Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Shares
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Financial Officer | Common SharesPurchase | 15,000$37.32 / share | $559.74K | Sep 30Filed Oct 1 · 1d later | SEC filing |
| PRESIDENT & CEO | Common SharesPurchase | 30,000$37.38 / share | $1.12M | Sep 30Filed Oct 1 · 1d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 5,144$8.15 / share | $41.92K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units5,144$8.15 exercise / conversion price | Not a separate purchase | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Chief Medical Officer | Common SharesSale10b5-12 trades | 7,068avg $60.25 / share | $425.83K | Aug 28Filed Aug 31 · 3d later | 2 filings
|
| Director | Common SharesSale | 10,000$64.06 / share | $640.55K | Aug 11Filed Aug 13 · 2d later | SEC filing |
| Director | Common SharesSale10b5-1 | 1,322$53.14 / share | $70.25K | Jun 5Filed Jun 8 · 3d later | SEC filing |
| Director | Common SharesSale10b5-1 | 1,190$53.14 / share | $63.24K | Jun 5Filed Jun 8 · 3d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 1,416$53.41 / share | $75.63K | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 2,645Price not reported | Unavailable | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common SharesExercise-price or tax withholding | 1,416$53.41 / share | $75.63K | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Restricted Share UnitsOption exercise or conversion | Derivative units2,645Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units10,507Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Restricted Share UnitsGrant or award | Derivative units1,593Award · no purchase price | Non-cash award | Jun 3Filed Jun 3 · 0d later | SEC filing |
| Director | Common SharesOption exercise or conversion | 3,500$7.38 / share | $25.83K | May 12Filed May 13 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units3,500$7.38 exercise / conversion price | Not a separate purchase | May 12Filed May 13 · 1d later | SEC filing |
$1,681,140 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
2 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.